HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis | Synapse
December 5, 2017Open Access
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
Key Points
Key points are not available for this paper at this time.
Abstract
Bill & Melinda Gates Foundation and World Health Organization.